Dr James Reilly T.D., Minister for Health, today (19/4/12) published a study commissioned by his Department to investigate a possible association between narcolepsy and the vaccine Pandemrix®. The study was carried out by an expert group led by Dr Darina O’Flanagan, Director of the Health Protection Surveillance Centre.
The study found an increased risk of developing narcolepsy in the 5-19 years age group who had received the Pandemrix® vaccine compared with those who had not received that vaccine.
These results are very similar to those seen in Sweden and Finland with a clear increased risk evident from the available data. However, it is very unlikely that the vaccine alone would be sufficient to explain what has been observed. International experts agree that a number of factors are likely to have contributed to the increased risk and a number of international studies are continuing which should provide additional information.
The Department of Health, in conjunction with the Health Services Executive (HSE) and the Department of Education and Skills are working together to put in place necessary supports for those people affected by this condition. These will include health and educational supports.
A copy of the report is available at www.dohc.ie/publications/Nat_Narcolespy_Study_SC_Report.html
Last updated: 19 April 2012
Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010: Final Report of National Narcolepsy Study Steering Committee
IMB reports on EMA statement on use of the Pandemrix vaccine
The Irish Medicines Board (IMB) has reported on the European Medicines Agency’s statement on the use of the Pandemrix vaccine and the onset of narcolepsy. Investigation into cases occurring in Ireland is on-going.
- European Medicines Agency completes review of Pandemrix – IMB 21 July 2011
- European Medicines Agency recommends restricting use of Pandemrix – EMA 21 July 2011
- Q&A on the review of Pandemrix Influenza vaccine – EMA 21 July 2011
- Recommendation by the European Medicines Agency concerning Pandemrix® vaccination and reports of narcolepsy in children and adolescents - ECDC 21 July 2011